{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:15:48Z","timestamp":1778505348857,"version":"3.51.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":5686,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.fertnstert.2006.08.012","type":"journal-article","created":{"date-parts":[[2006,10,19]],"date-time":"2006-10-19T09:22:58Z","timestamp":1161249778000},"page":"S229-S235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S","title":["Hormonal contraception: recent advances and controversies"],"prefix":"10.1016","volume":"86","member":"78","reference":[{"key":"10.1016\/j.fertnstert.2006.08.012_bib1","unstructured":"Speroff L, Glass RH, Kase NG, eds. Clinical gynecologic endocrinology and infertility. Baltimore 1999;867\u2013945."},{"key":"10.1016\/j.fertnstert.2006.08.012_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0010-7824(95)00014-2","article-title":"A multicentered phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women","volume":"51","author":"Sang","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0010-7824(99)00083-9","article-title":"Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7\/7\/7 oral contraceptive (norethindrone\/ethinyl estradiol triphasic)","volume":"60","author":"Kaunitz","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0010-7824(00)00183-9","volume":"62","author":"Garceau","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0010-7824(99)00081-5","article-title":"Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women","volume":"60","author":"Rahimy","year":"1999","journal-title":"Contraception"},{"issue":"Suppl 2","key":"10.1016\/j.fertnstert.2006.08.012_bib6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(01)03261-7","article-title":"Pharmacokinetic overview of Ortho Evra\/Evra","volume":"77","author":"Abrams","year":"2002","journal-title":"Fertil Steril"},{"issue":"Suppl 2","key":"10.1016\/j.fertnstert.2006.08.012_bib7","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\/Evra transdermal system: the analysis of pooled data","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib8","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0015-0282(01)01689-2","article-title":"Use of novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition","volume":"75","author":"Mulders","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/humrep\/16.3.469","article-title":"Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl estradiol","volume":"16","author":"Roumen","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-2001-18643","article-title":"Progestin-releasing intrauterine systems","volume":"19","author":"Luukkainen","year":"2001","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0010-7824(77)90001-4","article-title":"Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing IUD and a Nova-T-copper device","volume":"15","author":"Nilsson","year":"1977","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(01)00302-X","article-title":"Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years","volume":"65","author":"Hidalgo","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0002-9378(11)90607-3","article-title":"Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices","volume":"166","author":"Sivin","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib16","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1093\/humrep\/13.12.3371","article-title":"The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study","volume":"13","author":"Sivin","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0010-7824(98)00112-7","article-title":"Contraception with two levonorgestrel rod implants","volume":"58","author":"Sivin","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2001-18642","article-title":"Implant contraception","volume":"19","author":"Meckstroth","year":"2001","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib19","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1067\/mob.2001.117415","article-title":"Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy","volume":"185","author":"Hammond","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0015-0282(00)01747-7","article-title":"The emerging use of the 20-microg oral contraceptive","volume":"75","author":"Poindexter","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(99)00109-2","article-title":"Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations","volume":"60","author":"Rosenberg","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib23","first-page":"771","article-title":"Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial","volume":"98","author":"Miller","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(02)00445-6","article-title":"Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial","volume":"67","author":"Kwiecien","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(98)05718-3","article-title":"Timing of emergency contraception with levonorgestrel or the Yuzpe regimen","volume":"353","author":"Piaggio","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0010-7824(98)00042-0","article-title":"New estimates of the effectiveness of the Yuzpe regimen of emergency contraception","volume":"57","author":"Trussell","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0010-7824(99)00018-9","article-title":"Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception","volume":"59","author":"Trussell","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(98)05145-9","article-title":"Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib29","first-page":"271","article-title":"Meclizine for prevention of nausea associated with use of emergency contraceptive pills: a randomized trial","volume":"95","author":"Raymond","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0010-7824(00)00178-5","article-title":"Ectopic gestation following emergency contraceptive pill administration","volume":"62","author":"Nielsen","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib31","series-title":"ACOG practice bulletin no. 25: emergency oral contraception","year":"2001"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(98)07190-6","article-title":"Comparison of three single doses of mifepristone as emergency contraception: a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1471-0528.2002.01371.x","article-title":"A randomised study comparing a low dose of mifepristone and the Yuzpe regimen for emergency contraception","volume":"109","author":"Ashok","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib34","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199210083271501","article-title":"Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception","volume":"327","author":"Glasier","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib35","series-title":"SEER cancer statistics review, 1975\u20132000","author":"Ries","year":"2003"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib36","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib37","series-title":"Estrogens and progestogens in clinical practice","first-page":"831","article-title":"The influence of steroids on gynecologic cancers","author":"Schlesselman","year":"1999"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib38","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jama.1987.03390060086029","article-title":"Combination oral contraceptive use and the risk of endometrial cancer","volume":"257","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib39","first-page":"277","article-title":"Use of oral contraceptives and endometrial cancer risk (Sweden)","volume":"10","author":"Weiderpass","year":"1999","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib40","first-page":"186","article-title":"Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer","volume":"49","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib41","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0029-7844(95)00022-J","article-title":"Net effect of oral contraceptive use on the risk of cancer in women in the United States","volume":"85","author":"Schlesselman","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib42","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJM198703123161102","article-title":"The reduction in risk of ovarian cancer associated with oral contraceptive use","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jnci\/94.1.32","article-title":"Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk","volume":"94","author":"Schildkraut","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib45","first-page":"419","article-title":"The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer","volume":"83","author":"Gross","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<357::AID-IJC8>3.0.CO;2-1","article-title":"Smoking and oral contraceptives as risk factors for cervical carcinoma in situ","volume":"81","author":"Ylitalo","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib47","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1054\/bjoc.1999.1100","article-title":"Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection","volume":"82","author":"Kjellberg","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/gye.15.1.23.28","article-title":"The evidence for an etiological relationship between oral contraceptive use and dysplastic change in cervical tissue","volume":"15","author":"Salazar","year":"2001","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib49","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib51","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(02)08125-4","article-title":"Oral contraceptives, parity, and cervical cancer","volume":"359","author":"Skegg","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib52","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(02)08151-5","article-title":"Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study","volume":"359","author":"Munoz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib53","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1054\/bjoc.2000.1622","article-title":"Oral contraceptives and colorectal cancer risk: a meta-analysis","volume":"84","author":"Fernandez","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib54","first-page":"569","article-title":"Spinal bone density in women using depot medroxyprogesterone contraception","volume":"92","author":"Cundy","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib55","first-page":"736","article-title":"Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population","volume":"95","author":"Petitti","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib56","first-page":"576","article-title":"A prospective, controlled study of the effects of hormonal contraception on bone mineral density","volume":"98","author":"Berenson","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib57","unstructured":"American College of Obstetricians and Gynecologists. ACOG committee revises recommendations on OCs with third-generation progestins. ACOG Today 1998;July."},{"key":"10.1016\/j.fertnstert.2006.08.012_bib58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bmj.308.6923.247","article-title":"Recovery of bone density in women who stop using medroxyprogesterone acetate","volume":"308","author":"Cundy","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib59","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1365-2265.1998.00582.x","article-title":"The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women","volume":"49","author":"Orr-Walker","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib60","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-3476(96)70148-8","article-title":"A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives","volume":"129","author":"Cromer","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0010-7824(95)00121-P","article-title":"Differential effects on bone density of progestogen-only methods for contraception in premenopausal women","volume":"52","author":"Naessen","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib62","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2265.1993.tb02422.x","article-title":"Effects of norethisterone on bone related biochemical variables and forearm bone mineral in post-menopausal osteoporosis","volume":"39","author":"Horowitz","year":"1993","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib63","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1001\/archinte.1991.00400100053009","article-title":"Oral contraceptive use may protect against low bone mass","volume":"151","author":"Kleerekoper","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib64","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(98)09044-8","article-title":"Oral-contraceptive use and risk of hip fracture: a case-control study","volume":"353","author":"Michaelsson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib65","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0015-0282(01)01936-7","article-title":"Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate","volume":"76","author":"Perrotti","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib66","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/humupd\/5.6.721","article-title":"Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks","volume":"5","author":"Farley","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib67","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction","volume":"345","author":"Tanis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib68","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib69","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.STR.0000015345.61324.3F","article-title":"Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke","volume":"33","author":"Kemmeren","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.318.7175.13","article-title":"Migraine and stroke in young women: case-control study","volume":"318","author":"Chang","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib71","first-page":"1100","article-title":"Contraception for women in selected circumstances","volume":"99","author":"Curtis","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib72","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib73","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib74","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib75","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-2001-18638","article-title":"The risks of oral contraceptive pills","volume":"19","author":"Pymar","year":"2001","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib76","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib77","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2006.08.012_bib78","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.ATV.19.3.700","article-title":"Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis","volume":"19","author":"Martinelli","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028206032626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028206032626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:16:18Z","timestamp":1758006978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028206032626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0015028206032626"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2006.08.012","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormonal contraception: recent advances and controversies","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2006.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2004.07.935","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}